Edition:
United States

C-Rad AB (CRADb.ST)

CRADb.ST on Stockholm Stock Exchange

14.65SEK
11:29am EDT
Change (% chg)

0.20kr (+1.38%)
Prev Close
14.45kr
Open
14.95kr
Day's High
14.95kr
Day's Low
14.30kr
Volume
172,337
Avg. Vol
73,279
52-wk High
16.10kr
52-wk Low
8.00kr

CRADb.ST

Chart for CRADb.ST

About

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning,... (more)
No analyst recommendations are available for CRADb.ST.

Overall

Beta: 0.98
Market Cap(Mil.): kr414.26
Shares Outstanding(Mil.): 28.67
Dividend: --
Yield (%): --

Financials

  CRADb.ST Industry Sector
P/E (TTM): -- 51.19 30.12
EPS (TTM): -1.14 -- --
ROI: -45.92 6.69 13.28
ROE: -56.41 10.65 14.44

BRIEF-C-Rad Q1 net sales rise to SEK 25.8 million

* Q1 NET SALES SEK 25.8 MILLION VERSUS SEK 17.3 MILLION YEAR AGO

2:35am EDT

BRIEF-C-RAD sells SIGRT solution to Miami Cancer Institute

* MIAMI CANCER INSTITUTE DECIDES FOR C-RAD'S SIGRT SOLUTION FOR THEIR NEW PROTON CENTER IN MIAMI, FLORIDA

Apr 18 2017

BRIEF-C-Rad Q4 operating loss narrows to SEK 4.4 million

* Q4 net sales 27.3 million Swedish crowns ($3 million) versus 20.1 million crowns year ago

Feb 13 2017

BRIEF-C-Rad to provide cancer centers in Texas with surface tracking systems

* C-Rad and MD Anderson Cancer Center concluded agreement to supply SIGRT solution

Jan 30 2017

BRIEF-C-Rad: appeal in patent dispute over C-Rad'S right to patent granted

* Appeal in patent dispute over C-Rad's right to patent granted

Jan 24 2017

BRIEF-C-RAD: Appeal in patent dispute

* Stockholm Patent and Market Court confirmed in its verdict C-RAD's right to invention

Nov 21 2016

BRIEF-C-Rad Q3 net sales sek up at SEK 22.5 million

* Q3 net sales 22.5 million Swedish crowns ($2.5 million) versus 15.4 million crowns year ago

Nov 21 2016

BRIEF-C-Rad receives an order from a private hospital in Ireland

* St. Vincent's Private Hospital First Customer In Ireland For Advanced C-Rad Catalyst System

Nov 16 2016

BRIEF-C-Rad Q3 operating loss widens to SEK 7.9 million

* Q3 net sales 22.5 million Swedish crowns ($2.5 million) versus 15.4 million crowns year ago

Nov 14 2016

BRIEF-C-RAD gets first two orders from General Electric

* Total order value is about 1 million Swedish crowns ($111,567.30)

Nov 09 2016

More From Around the Web

Earnings vs. Estimates